Eulerpool Data & Analytics INHIBIKASE THERAPEUTICS, INC. WILMINGTON, US-DE
Naam
INHIBIKASE THERAPEUTICS, INC.
Adres
INHIBIKASE THERAPEUTICS, INC.
c/o PHS CORPORATE SERVICES
INC.
1313 N MARKET ST STE 5100
19801 WILMINGTON
Hoofdkantoor
3350 Riverwood Parkway Southeast; Suite 1900, 30339 Atlanta
Legal Entity Identifier (LEI)
549300066CFEWOA17F12
Legal Operating Unit (LOU)
5299000J2N45DDNE4Y28
Registreren
4832244
Bedrijfsvorm
XTIQ
Bedrijfscategorie
Algemeen
Status
Uitgegeven
Validatiestatus
Volledig bevestigd
Laatst bijgewerkt
29-8-2023
Volgende vernieuwing
29-8-2024
Eulerpool API INHIBIKASE THERAPEUTICS, INC. Omzet, winst, balans, patenten, werknemers en meer WILMINGTON, US-DE
{
"lei": "549300066CFEWOA17F12",
"legal_jurisdiction": "US-DE",
"legal_name": "INHIBIKASE THERAPEUTICS, INC.",
"entity_category": "GENERAL",
"entity_legal_form_code": "XTIQ",
"legal_first_address_line": "c/o PHS CORPORATE SERVICES, INC., 1313 N MARKET ST STE 5100",
"legal_additional_address_line": "",
"legal_city": "WILMINGTON",
"legal_postal_code": "19801",
"headquarters_first_address_line": "3350 Riverwood Parkway Southeast; Suite 1900",
"headquarters_additional_address_line": "",
"headquarters_city": "Atlanta",
"headquarters_postal_code": "30339",
"registration_authority_entity_id": "4832244",
"next_renewal_date": "2024-08-29T13:00:07.000Z",
"last_update_date": "2023-08-29T13:00:07.000Z",
"managing_lou": "5299000J2N45DDNE4Y28",
"registration_status": "ISSUED",
"validation_sources": "FULLY_CORROBORATED",
"reporting_exception": "",
"slug": "INHIBIKASE THERAPEUTICS, INC.,WILMINGTON,4832244"
}Andere bedrijven in dezelfde jurisdictie